Skip to main content

ASND · Ascendis Pharma A/S · Analyst Estimates

Track ASND — free
$271.19 -0.54 (-0.20%) At close · Nov 17 Play latest call Q2 2026 earnings call transcript
Market Cap
$17.79B
Shares
65.60M
Volume · Nov 17 586.93K Avg daily vol (3M) 735.38K

Analyst Estimates

Compare analyst forecasts for Ascendis Pharma A/S across metrics and forecast periods.

Estimates are grouped by forecast period, with low, average and high together. A dash means that statistic is not available.

Pull consensus estimates through the analyst estimates API or MCP →

Compiled consensus

These figures are a compiled consensus of analyst forecasts, not a survey the company published itself. Every figure is the statistic the source states; averages are means, never medians.

Captured 2026-11-15 18:33 UTC · Publication dates shown per estimate · 8 metric / period groups

FY ending 2026-12-31

Analyst estimates for FY ending 2026-12-31
Metric Low Average High Analyst count Average, 7 days ago Average, 30 days ago Average, 60 days ago Average, 90 days ago Estimates lowered, last 7 days Estimates lowered, last 30 days Estimates raised, last 7 days Estimates raised, last 30 days
EPS
EUR
Publication date not stated
4.52
12.37
18.15
7
10.08
12.79
12.77
11.34
1
1
1
1
Revenue
EUR
Publication date not stated
1.35B
1.38B
1.51B
17
— — — — — — — —

FY ending 2027-12-31

Analyst estimates for FY ending 2027-12-31
Metric Low Average High Analyst count Average, 7 days ago Average, 30 days ago Average, 60 days ago Average, 90 days ago Estimates lowered, last 7 days Estimates lowered, last 30 days Estimates raised, last 7 days Estimates raised, last 30 days
EPS
EUR
Publication date not stated
8.44
10.78
16.66
7
8.90
9.62
9.67
8.16
1
2
— —
Revenue
EUR
Publication date not stated
1.89B
2.02B
2.30B
18
— — — — — — — —

Q ending 2026-12-31

Analyst estimates for Q ending 2026-12-31
Metric Low Average High Analyst count Average, 7 days ago Average, 30 days ago Average, 60 days ago Average, 90 days ago Estimates lowered, last 7 days Estimates lowered, last 30 days Estimates raised, last 7 days Estimates raised, last 30 days
EPS
EUR
Publication date not stated
1.57
1.90
2.71
4
1.39
1.16
1.18
1.18
1
1
0
0
Revenue
EUR
Publication date not stated
395.90M
414.83M
434.80M
17
— — — — — — — —

Q ending 2027-03-31

Analyst estimates for Q ending 2027-03-31
Metric Low Average High Analyst count Average, 7 days ago Average, 30 days ago Average, 60 days ago Average, 90 days ago Estimates lowered, last 7 days Estimates lowered, last 30 days Estimates raised, last 7 days Estimates raised, last 30 days
EPS
EUR
Publication date not stated
1.52
1.52
1.52
1
1.08
1.08
1.15
1.15
1
1
0
0
Revenue
EUR
Publication date not stated
424.00M
445.88M
477.00M
6
— — — — — — — —
Key facts CIK 1612042 CUSIP K08588103 13F (30d) 363 filings 333 filers Visit website Investor relations